Evidence for newborn screening for cystic fibrosis

Paediatric Respiratory Reviews

Volumn 4, Issue 4, 2003, Pages 278-284

  Castellani, Carlo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Cystic fibrosis; Neonatal screening; Observational studies; Randomised studies

Indexed keywords

CHILDHOOD DISEASE; CLINICAL STUDY; CYSTIC FIBROSIS; HUMAN; INTERMETHOD COMPARISON; LUNG DISEASE; MALNUTRITION; MEDICAL DECISION MAKING; MEDICAL INFORMATION; NEWBORN; NEWBORN MORTALITY; NEWBORN SCREENING; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0344234470     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1526-0542(03)00085-X     Document Type: Review

References (31)

1. Accurso FJ, Wagener JS, Sontag MK, Hammond KB. Strategies for effective clinical intervention in cystic fibrosis. In: Travert G, Wursteisen B (eds) Neonatal Screening for Cystic Fibrosis. Caen: Presses Universitaires de Caen, 1999; 199-207.
2. Kahn TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 1075-1082.
3. Castile RG, Long FR, Flucke RL, Hayes JR, McCoy KS. Correlations of structural and functional abnormalities in the lungs of infants with cystic fibrosis. Pediatr Pulmonol 2000: S20: 295.
4. Corey M. Requirements for assessing possible benefits of screening-fundamental problems of comparing screened and unscreened groups of cystic fibrosis patients. In: Travert G, Wursteisen B (eds) Neonatal Screening for Cystic Fibrosis. Caen: Presses Universitaires de Caen, 1999; 289-299.
5. Peckham CS, Dezateaux C. Issues underlying the evaluation of screening programmes. Br Med Bull 1998: 54: 767-778.
6. Cono J, Khoury MJ. An epidemiological evaluation of newborn screening for cystic fibrosis: a scientific challenge for public health action. MMWR Morb Mortal Wkly Rep 1997; 46 RR-16: 4-5.
7. Waters DL, Wilcken B, Irwig L et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999; 80: F1-F7.
8. Dankert-Roelse JE, te Meerman GJ. Long-term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995; 50: 712-718.
9. Dankert-Roelse JE, te Meerman GJ, Martijn A, ten Kate LP, Knol K. Survival and clinical outcome in patients with cystic fibrosis, with and without screening. J Pediatr 1989; 114: 362-367.
10. Merelle ME, Schouten JP, Gerritsen J, Dankert-Roelse JE. Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients. Eur Respir J 2001; 18: 306-315.
11. Mastella G, Zanolla L, Castellani C et al. Neonatal screening for cystic fibrosis: long-term clinical balance. Pancreatology 2001; 1: 531-537.
12. Assael BM, Castellani C, Barao Ocampo M, Iansa P, Callegaro A, Valsecchi MG. Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol 2002; 156: 397-401.
13. Dezateux C. Evaluating newborn screening programmes based on dried blood spots: future challenges. Br Med Bull 1998; 54: 877-890.
14. Chatfield S, Owen G, Ryley HC et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991; 66: 29-33.
15. Doull IJM, Ryley HC, Weller P, Goodchild MC. Cystic fibrosis-related deaths and the effect of newborn screening. Pediatr Pulmonol 2001; 31: 363-366.
16. Farrell PM, Kosorok MR, Laxova A et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997; 337: 963-969.
17. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Farrell PM, Kosorok MR, Rock MJ et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Pediatrics 2001; 107: 1-13.
18. Farrell PM, Kosorok MR, Rock MJ et al. Lung disease in patients with cystic fibrosis diagnosed through neonatal screening or after delays associated with traditional methods. Pediatr Pulmonol 2002; S24: 319.
19. Dodge JA. Cystic fibrosis should be added to diseases sought in all newborn babies. Lancet 1998; 317: 411.
20. Pollitt R. Early diagnosis is important to parents even if it makes little difference to outcome. BMJ 1998; 317: 411-412.
21. Helton JL, Harmon RJ, Robinson N, Accurso FJ. Parental attitudes toward newborn screening for cystic fibrosis. Pediatric Pulmonol 1991: 7(Suppl.): 23-28.
22. Lane B, Harris R, Harris H. Early diagnosis allows option for prenatal diagnosis in subsequent pregnacies. BMJ 1998; 317: 411.
23. Mischler EH, Wilfond BS, Fost N, Laxova A, Reiser C, Sauer CM. Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling. Pediatrics 1998; 102: 44-52.
24. Dudding T, Wilcken B, Burgess B, Hambly J, Turner G. Reproductive decisions after neonatal screening identifies cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 2000; 82: F124-F127.
25. Balnaves ME, Bonacquisto L, Francis I, Glazner J, Forrest S. The impact of newborn screening on cystic fibrosis testing in Victoria, Australia. J Med Genet 1995; 32: 537-543.
26. Perobelli S, Faraguna D, Giglio L et al. False positive screening for cystic fibrosis: reactions in parents and attitudes of professionals. Proceedings de conference internationale mucoviscidose, University of Caen, October 5-6 1988; 203-214.
27. Castellani C. Extensive genetic analysis for neonatal screening. In: Romano L, Manno G, Galieta LJV (eds) Proceedings of the 25th European Cystic Fibrosis Conference. Bologna: Monduzzi; 2002; 77-81.
28. Castellani C, Benetazzo MG, Tamanini A, Begnini A, Mastella G, Pignatti PF. Analysis of the entire coding region of the cystic fibrosis transmembrane regulator gene in neonatal hypertrypsinemia with normal sweat test. J Med Genet 2001; 38: 202-205.
29. Kosorok MR, Jalaluddin M, Farrell PM et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998; 26: 81-88.
30. Merelle ME, Nagelkerke AF, Lees CM, Dezateux C. Newborn screening for cystic fibrosis (Cochrane Review). In: The Cochrane Library. Oxford: Update Software Issue 3, 1999.
31. Connett GJ, Yeatman SL. Delayed diagnosis in cystic fibrosis patients homozygous for deltaF508 mutation results in increased treatment to maintain health in childhood. Pediatr Pulmonol 2002; S24: 318.